pozelimab
toripalimab
sasanlimab
lintuzumab
antimonoclonal
carlumab
ozogamicin
panitumumab
lexatumumab
inotuzumab ozogamicin
agonistic monoclonal antibody
drozitumab
monoantibody
-mab
polyclonal
-xizu-
cibisatamab
bococizumab
sibrotuzumab
immunoglobulin E
hyperimmunoglobulin
alacizumab
immunoadsorbent
atezolizumab
chromobody
oportuzumab monatox
-lim-
lucatumumab
polyantigenic
durvalumab
glucoincretin
dalotuzumab
aritox
horseradish peroxidase
nofetumomab
multiantigenic
antisubstance
immunoantigen
tabalumab
xenoantibody
faralimomab
antihuman
pritumumab
brentuximab
ABO antibodies
-toxa-
Forssman antibody
seroconversion
heterophil antibody
heterophile antibody